Proactive research analyst says Tiziana Life Sciences "moving forward quite nicely"

In this article:

New York, USA --News Direct-- Tiziana Life Sciences PLC

Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a 2023 Clinical Outlook for clinical stage biotechnology company Tiziana Life Sciences Ltd (NASDAQ:TLSA). He gives his take on what the market can expect from the business this year, saying that it is now "moving forward quite nicely."

Proactive UK Finance News

Contact Details

Proactive UK Ltd

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/proactive-research-analyst-says-tiziana-life-sciences-moving-forward-quite-nicely-546792176

Advertisement